implant

US-based Implant Sciences has won a contract to supply its QS-B220 desktop explosives trace detectors to Romanian airports.

The QS-B220 employs Ion Mobility Spectrometry (IMS) that helps in the rapid detection and identification of traces of an array of military, commercial, and homemade explosives.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The company claims that the equipment can be deployed at a low cost due to its lower maintenance requirements in comparison to other competing systems.

Implant Sciences global sales and marketing vice-president Dr Darryl Jones said: "Implant Sciences has, in this year, doubled the number of units sold in its entire history of selling trace detectors.

"This sale to Romania is another example of smaller EU country airports following market trends set by other, larger airports."

See Also:

"This sale to Romania is another example of smaller EU country airports following market trends set by other, larger airports."

The QS-B220 features a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal internal automatic calibration system.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Implant Sciences CEO Dr Bill McGann said: "Over the last several months, our QS-B220 has been recognised by some of the most high-profile airport security operators and ETD customers in the world, being selected in tenders across ten different EU countries."

Implant Sciences specialises in manufacturing explosives trace detection (ETD) and drugs trace detection systems for homeland security applications and has, to date, sold around 4,400 QS-B220 units worldwide.

Since April, Implant has sold 800 QS-B220 to various airports internationally. In July alone, it sold 50 detectors to various airports in Germany, 45 in Czech Republic, and 178 units to the three major airports in Paris. Around 95% of the major airports in France are now using QS-B220.

Image: The Implant Sciences QS-B220 has lower maintenance requirements in comparison to other competing systems. Photo: courtesy of Implant Sciences Corporation